Jeffrey Clogston

Jeffrey Clogston

Company: Leidos Biomedical Research

Job title: Principal Scientist & Head of Physicochemical Characterization Section

Bio:

Dr. Jeffrey D. Clogston is a Principal Scientist and the Head of the physicochemical characterization section at the Nanotechnology Characterization Laboratory (NCL). In his role, Dr. Clogston conducts physicochemical characterization and standardization of nanoparticles, develops new analytical methodology for critical quality attributes, and assesses current instrumentation for nanoparticle characterization. Dr. Clogston has been with the lab for over 19 years. During this time, Dr. Clogston has helped to establish many protocols for nanoparticle characterization, working collaboratively with experts at the National Institute of Standards and Technology and standards organizations such as ASTM International and International Organization for Standardization. Throughout his tenure, Dr. Clogston has published nearly 60 manuscripts describing new analytical techniques for various nanoparticle platforms, keeping pace with the quick evolution of the nanomedicine field. Prior to joining the NCL in March 2006, Dr. Clogston received his Ph.D. in chemical engineering from The Ohio State University. His research dissertation was on the application of the lipidic cubic phase for drug delivery, wastewater remediation, and membrane protein crystallization. His areas of expertise include physicochemical characterization of and in vitro release from lipid- and polymer-based drug delivery systems, development of novel analytical methodologies to address characterization challenges and gaps, and protein and lipid biochemistry.

Seminars:

Workshop A – Providing a Comprehensive Overview of Core Analytical Methods & Assays for Successful Regulatory Submissions & Batch Release of LNP-Mediated Drugs 8:30 am

Unlock the fundamental and critical analytical strategies behind successful LNP drug development in this hands-on 101 workshop. Gain a clear understanding of essential QC release assays, enabling accurate execution to meet regulatory expectations and confidently drive your LNPs from lab to market. Delving into a regulatory-focused list of required QC release assays for robust regulatory…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.